GT Biopharma GTBP
NASDAQ GTBP
$5.52 +0.11 (+2.03%)
At close: Oct 22, 2026 · 4:00 PM EDT

GT Biopharma (GTBP) Change in Receivables (2014)

Updated

GT Biopharma (GTBP) reported Change in Receivables of $35,000 for Q3 2014.

Analysis

GT Biopharma (GTBP) Change in Receivables (2014) Analysis & Trends

For FY2013, GT Biopharma posted Change in Receivables of $40,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -188.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 1.37 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 333.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 GT Biopharma 7.77 Mn -15.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 35,000.00
Jun 30, 2014 -25,000.00
Mar 31, 2014 -10,000.00
API Access

GT Biopharma Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=GTBP&period=max&api_key=YOUR_API_KEY